STD Diagnostics Market Share, Growth, Region Wise Analysis of Top Players and Forecasts 2022
28th Dec 2020 - The global STD Diagnostics Market is anticipated to witness a higher CAGR in the forecast period. Sexually transmitted infections caused by HIV type 1 and type 2 pose as important study areas with reference to public health. Rise in mortality rate, cervical cancer, ectopic pregnancy and infertility as well as HIV-related illness, all leads to empirical study of HIV and STD simultaneously. Under a syndromatic approach, STD’s rely on using flowcharts for individual STI syndrome. The flowcharts allow diagnoses of common STD syndromes and availability of drugs and medication provision in a specific country.
The market for STD
diagnostics is highly driven by rise in R&D activities and a significant
shift observed in laboratory testing to point of care testing. Increasing cases
of having multiple sex partners and practicing unsafe sex is likely to
contribute in augmenting the market size in the near future. In addition, rise
in drug addiction is indirectly proportional to the market growth.
Access STD Diagnostics
Market Report with TOC @ https://www.millioninsights.com/industry-reports/std-diagnostics-market
Global STD Diagnostics Type Outlook (Revenue, USD Billion, 2012 -
2022)
• Chlamydia testing
• Syphilis testing
• Gonorrhea testing
• Herpes Simplex Virus testing
• Human Papilloma Virus testing
• Human Immunodeficiency Virus testing
• Chancroid testing
• Others
Global STD Diagnostics Location of Testing Outlook (Revenue, USD
Billion, 2012 - 2022)
• Laboratory Testing
• Commercial/Private Labs
• Public Health Labs
• Point of Care (PoC) testing
The key players in the STD diagnostics market include HologicInc, Danaher Corporation, and bioMerieux, Cepheid Inc, AlereInc, HologicInc, Abbott Laboratories, Roche Holdings AG, Affymetrix, Becton Dickinson, Orasure and DiaSorin. The key players emphasize effective collaboration and strategic alliances pertaining to technology.
Request a Sample Copy
of STD Diagnostics Market Report @ https://www.millioninsights.com/industry-reports/std-diagnostics-market/request-sample
Geographical segmentation
for STD diagnostics market include North America, Latin America, Europe,
Asia-Pacific, Middle East and Africa. North America STD diagnostics industry is
anticipated to rise at a significant CAGR in the forthcoming period due to prevalence
of health insurance plans and availability of FDA approved testing devices
bolsters the market growth in the near future. Europe market is anticipated to
grow at a significant CAGR in the forecast period.
Asia-Pacific region
accounts for a higher share in the regional market accounting for a strong
market position in the global scenario. APAC regions possess a high number of
sexually transmitted diseases with an immediate need for medical attention and
positive initiatives by NGO to create hygiene awareness among sex workers.
Comments
Post a Comment